Oleolive extracts oleocanthal from extra virgin olive oil for preventative and therapeutic treatments for Alzheimer's Disease and a particular form of breast cancer. The company was formed with the goal of making oleocanthal commercially available after University of Louisiana Monroe researchers discovered its anti-aging benefits and preventative and therapeutic qualities for neurology and oncology treatment. Oleolive has received grants from the National Institute of Health’s National Institute on Aging, the National Cancer Institute and the U.S. Department of Defense.

‍